000 | 01366 a2200421 4500 | ||
---|---|---|---|
005 | 20250516013342.0 | ||
264 | 0 | _c20120314 | |
008 | 201203s 0 0 eng d | ||
022 | _a1476-5365 | ||
024 | 7 |
_a10.1038/bmt.2010.285 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFontanet, A | |
245 | 0 | 0 |
_aCotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. _h[electronic resource] |
260 |
_bBone marrow transplantation _cSep 2011 |
||
300 |
_a1272-3 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Infective Agents _xadverse effects |
650 | 0 | 4 |
_aBlood Platelets _xphysiology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHematologic Diseases _xblood |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeutrophils _xphysiology |
650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xadverse effects |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aChalandon, Y | |
700 | 1 | _aRoosnek, E | |
700 | 1 | _aMohty, B | |
700 | 1 | _aPassweg, J R | |
773 | 0 |
_tBone marrow transplantation _gvol. 46 _gno. 9 _gp. 1272-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/bmt.2010.285 _zAvailable from publisher's website |
999 |
_c20396013 _d20396013 |